ERBB2 and neoplasm: To investigate the tumor-associated antigen-specific affinity of the bispecific antibody using Trastuzumab scFv (S4xTrastuzumab) on HER2-positive SKBR-331 and HER2 low-expressing HeLa cells,32 we conducted on-cell-binding assays using flow cytometry (Figure 3A).